Medical Cannabis Market is Growing at a Substantial CAGR of 15.4% During Forecats to 2025
MRFR has Reported new research on “Medical Cannabis Market-Global Forecast to 2025”
Market
Insights
Marijuana,
also known as cannabis, is a shrub that contains a chemical known as cannabis
and has healing properties. This plant is used by various pharmaceutical
companies as raw material to produce medicines for various therapeutic
applications. The permitted use of cannabis for wellness and medical purposes
is increasing, but varies by region, depending on the possession, distribution,
culture and medical indications for its use.
The Medical Cannabis Market Analysis is
projected to reach a valuation of USD 52.35 billion and attain a CAGR of 15.4%
during the forecast period (2019-2025).
The
sturdy progress of the global medical marijuana market is due to several
factors, such as the increased use of marijuana, the growing prevalence of
chronic diseases and other medical conditions, the increasing legalization of
medical marijuana in different countries, increased research and development on
cannabinoids. However, the increasing use of illegal cannabis is likely to slow
the growth of the global medical cannabis market.
Market
Segmentation
·
The global medical cannabis
market is bifurcated by product form, by-product, application, and end-user.
·
The market, based on product
form, is divided into powders, solids, ointments and creams, oils, and others.
The powder segment is predicted to grow rapidly during the evaluation period as
the powder dissolves easily in any liquid; this greatly increases the chances
of patients consuming their marijuana products for medicinal purposes. Thus,
the easy consumption of powdered products will considerably stimulate market
growth.
·
The global Medical
Cannabis Market for is divided into cannabidiol (CBD) and
tetrahydrocannabinol (THC) based on their derivatives. The cannabidiol (CBD)
segment is expected to dominate most of the market as it is mainly used to
treat pain and various other medical conditions.
·
The global medical cannabis
market is classified depending on its applications in arthritis, cancer,
Alzheimer's disease, schizophrenia, and others. Alzheimer's disease is
anticipated to lead the market, with about 5.7 million Americans of all ages
living with Alzheimer's disease and dementia.
·
Based on the distribution
channels, the global medical cannabis market is bifurcated into retail
pharmacies, online stores, and others. The retail pharmacy segment is expected
to have the largest market share, with most retailers and pharmacies supplying
cannabis worldwide.
Regional
Outlooks
As the
global medical cannabis market is emerging swiftly in various developed nations
with well-defined regulations for marijuana production and distribution, the
Americas leads the global market and is anticipated to sustain its dominance in
the during the forecast period.
The European
market for medical cannabis is predicted to show growth trends owing to well-established
medical facilities and research infrastructure, and prevalence of chronic
conditions.
Asia
Pacific market is projected to swift growth trends in the medical cannabis
market. Growing prevalence of cancer cases and the elderly population.
Growing
funding and healthcare expenditure in the Middle East and Africa are expected
to drive the growth of the region market at a moderate pace.
Market
Participants
The global
medical cannabis market is supported by various marijuana production and processing
companies with their deep research affiliated to the reap out maximum benefits
out of the plant in terms of medical applications. Some of these key players
are Tilray, Cannabis Sativa Inc., GW Pharmaceuticals PLC, Aphria, Inc, Canopy
Growth Corporation, CanniMed Ltd, United Cannabis, Aurora Cannabis, MediPharm
Labs, Medical Marijuana, Inc., GBSciences Inc, and Maricann Inc.
Access
Full Report Details @ https://www.marketresearchfuture.com/reports/medical-cannabis-market-8368
RecentUpdates
The
Utah Department of Health, a agency in the state of Utah, U.S.,
has started calling applicants to function pharmacies dedicated to medical
marijuana in the state. The department will provide licenses to 14 pharmacies.
The application of pharmacies will be thoroughly evaluated based on the
criteria under the Medical Cannabis Act and request for proposals. The County
Commission of Utah has also designated certain industrial and residential zone
to be for cannabis production.
Comments
Post a Comment